04/07/2025
5:52 PM | Aldeyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SCHEDULE 13G/A | |
04/07/2025
5:43 PM | Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:50 PM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
4:19 PM | Aldeyra Therapeutics (Filer)
| Form 10-K/A | |
03/06/2025
3:13 PM | Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:03 PM | Aldeyra Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025
3:36 PM | Aldeyra Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
11/18/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:50 PM | Aldeyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
10/21/2024
7:22 PM | Aldeyra Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ALDX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aldeyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
09/10/2024
3:15 PM | Aldeyra Therapeutics (Issuer)
Alfieri Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
8:02 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
3:24 PM | Aldeyra Therapeutics (Issuer)
Greenberg Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:24 PM | Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
5:07 PM | Aldeyra Therapeutics (Subject)
Greenberg Bruce (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
4:45 PM | Aldeyra Therapeutics (Subject)
Machatha Stephen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
6:06 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
11:15 PM | Aldeyra Therapeutics (Filer)
| Form EFFECT | |
04/22/2024
3:11 PM | Aldeyra Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:13 PM | Aldeyra Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:18 PM | Aldeyra Therapeutics (Filer)
| Form ARS | |
Buy ALDX Stock Free ALDX Stock Alerts